A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF URVARUKA GHRITA MATRA BASTI (Medicated ghee enema) AND KSHEERABALA TAILA MATRA BASTI (Medicated oil enema) ON PRASAVA (labour)
Phase 2
Completed
- Conditions
- Health Condition 1: O80- Encounter for full-term uncomplicated delivery
- Registration Number
- CTRI/2019/01/016893
- Lead Sponsor
- DR RAKSHA S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
PATIENT AGE GROUP BETWEEN 18-35 YEARS
PRIMI GRAVIDA AT 38 WEEKS OF PREGNANCY
Exclusion Criteria
HIGH RISK PREGNANCY
PRESENTATION OTHER THAN VERTEX
MULTIPLE PREGNANCY
PATIENTS HAVING HISTORY OF ANY OTHER SYSTEMIC ILLNESS THAT MAY INTERFERE WITH THE COURSE OF TREATMENT
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EFFICACY OF INTERVENTION OVER SUKHA PRASAEFFICACY OF INTERVENTION OVER SUKHA PRASAVATimepoint: 37 weeks to Date of delivery for 9 days of intervention and follow up upto delivery
- Secondary Outcome Measures
Name Time Method ILTimepoint: NA
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Urvaruka Ghruta Matra Basti's effects on uterine contractions during labor?
How does Ksheerabala Taila Matra Basti compare to oxytocin in accelerating full-term uncomplicated delivery (O80)?
Are there specific biomarkers that predict response to Ayurvedic enema therapies in CTRI/2019/01/016893?
What adverse events are associated with medicated ghee/oil enemas in phase II labor interventions?
What combination therapies with Ayurvedic basti show synergistic effects for PRASAVA in clinical trials?